These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Lack of correlation between serum anti-HBcore detectability and hepatocellular carcinoma in patients with HCV-related cirrhosis. Stroffolini T, Almasio PL, Persico M, Bollani S, Benvegnù L, Di Costanzo G, Pastore G, Aghemo A, Stornaiuolo G, Mangia A, Andreone P, Stanzione M, Mazzella G, Saracco G, Del Poggio P, Bruno S, Italian Association of the Study of the Liver Disease (AISF). Am J Gastroenterol; 2008 Aug; 103(8):1966-72. PubMed ID: 18637087 [Abstract] [Full Text] [Related]
5. HBsAg-negative hepatitis B virus infections in hepatitis C virus-associated hepatocellular carcinoma. Momosaki S, Nakashima Y, Kojiro M, Tabor E. J Viral Hepat; 2005 May; 12(3):325-9. PubMed ID: 15850475 [Abstract] [Full Text] [Related]
9. Clinical features of HBsAg-negative but anti-HBc-positive hepatocellular carcinoma in a hepatitis B virus endemic area. Shim J, Kim BH, Kim NH, Dong SH, Kim HJ, Chang YW, Lee JI, Chang R. J Gastroenterol Hepatol; 2005 May; 20(5):746-51. PubMed ID: 15853989 [Abstract] [Full Text] [Related]
10. Anti-hepatitis B core positivity as a risk factor for hepatocellular carcinoma in alcoholic cirrhosis: a case-control study. Kwon OS, Jung YK, Bae KS, Kim JH, Kim SG, Kim YS, Lee JI, Lee JW, Kim YS. Alcohol; 2012 Sep; 46(6):537-41. PubMed ID: 22572059 [Abstract] [Full Text] [Related]
13. The role of previous infection of hepatitis B virus in Hbs antigen negative and anti-HCV negative Japanese patients with hepatocellular carcinoma: etiological and molecular biological study. Matsuzaki Y, Sato M, Saito Y, Karube M, Doy M, Shoda J, Abei M, Tanaka N, Hadama T, Kinoshita M. J Exp Clin Cancer Res; 1999 Sep; 18(3):379-89. PubMed ID: 10606185 [Abstract] [Full Text] [Related]
17. Antibody to hepatitis B core antigen is associated with the development of hepatocellular carcinoma in hepatitis C virus-infected persons: a 12-year prospective study. Tanaka K, Nagao Y, Ide T, Kumashiro R, Sata M. Int J Mol Med; 2006 May; 17(5):827-32. PubMed ID: 16596267 [Abstract] [Full Text] [Related]
18. Clinical features of hepatocellular carcinoma seronegative for both HBsAg and anti-HCV antibody but positive for anti-HBc antibody in Japan. Yano Y, Yamashita F, Sumie S, Ando E, Fukumori K, Kiyama M, Oyama T, Kuroki S, Kato O, Yamamoto H, Tanaka M, Sata M. Am J Gastroenterol; 2002 Jan; 97(1):156-61. PubMed ID: 11808941 [Abstract] [Full Text] [Related]
19. Impact of hepatitis B and C virus infection on the clinical prognosis of alcoholic liver cirrhosis. Yamanaka T, Shiraki K, Nakazaawa S, Okano H, Ito T, Deguchi M, Takase K, Nakano T. Anticancer Res; 2001 Jan; 21(4B):2937-40. PubMed ID: 11712790 [Abstract] [Full Text] [Related]
20. Analysis of risk factors for hepatocellular carcinoma that is negative for hepatitis B surface antigen (HBsAg). Shimada S, Aizawa R, Abe H, Suto S, Miyakawa Y, Aizawa Y. Intern Med; 2003 May; 42(5):389-93. PubMed ID: 12793707 [Abstract] [Full Text] [Related] Page: [Next] [New Search]